Skip to main content
Clinical Trials/NCT03214029
NCT03214029
Active, not recruiting
Not Applicable

COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial

Hennepin Healthcare Research Institute1 site in 1 country2,000 target enrollmentNovember 6, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Myocardial Infarction
Sponsor
Hennepin Healthcare Research Institute
Enrollment
2000
Locations
1
Primary Endpoint
Diagnostic outcome analytical comparison of high-sensitivity cardiac troponin I and T assays for the diagnosis of acute myocardial injury and infarction.
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

Compare the analytical and clinical performance of hs-cTnI and hs-cTnT assays for the diagnosis of acute myocardial injury and myocardial infarction in patients presenting to the emergency department in whom serial cTnI measurements are obtained on clinical indication.

Detailed Description

Background: Comparative studies addressing the analytical and clinical performance of hs-cTnI and hs-cTnT assays for the diagnosis of acute myocardial injury and myocardial infarction in consecutive patients presenting to a United States (US) emergency department are lacking. Study objective: Compare the analytical and clinical performance of hs-cTnI and hs-cTnT assays for the diagnosis of acute myocardial injury and myocardial infarction in patients presenting to the emergency department in whom serial cTnI measurements are obtained on clinical indication. Null Hypothesis: hs-cTnI and or hs-cTnT assays will offer comparable diagnostic performance for acute myocardial injury and acute myocardial

Registry
clinicaltrials.gov
Start Date
November 6, 2017
End Date
December 31, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult, defined as subject 18 years of age or older
  • Baseline cTn measurement and at least one additional cTn measurement within 6 hours after initial cTnI measurement.
  • At least one 12-lead electrocardiogram

Exclusion Criteria

  • Currently pregnant
  • Trauma related admission
  • Cardiac arrest
  • Decline to participate
  • Did not present through the ED
  • Transferred from an outside hospital

Outcomes

Primary Outcomes

Diagnostic outcome analytical comparison of high-sensitivity cardiac troponin I and T assays for the diagnosis of acute myocardial injury and infarction.

Time Frame: on admission

Diagnostic performance of cardiac troponin assays for the diagnosis of acute myocardial injury and myocardial infarction

Secondary Outcomes

  • All-cause mortality(Up to 180-days)
  • Cardiac death(Up to 180-days)
  • Unstable angina(Up to 180-days)
  • Acute myocardial infarction(Up to 180-days)
  • Revascularization(Up to 180-days)
  • Safety outcome: Major adverse cardiac events: cardiac death, unstable angina, acute myocardial infarction, revascularization, and congestive heart failure.(30-days)

Study Sites (1)

Loading locations...

Similar Trials